Drug Shortage Report for ACTEMRA

Last updated on 2021-11-25 History
Report ID 144437
Drug Identification Number 02350106
Brand name ACTEMRA
Common or Proper name ACTEMRA
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) TOCILIZUMAB
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 200MG/10ML 1VIAL
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-30
Actual start date 2021-10-18
Estimated end date 2022-01-31
Actual end date
Shortage status Actual shortage
Updated date 2021-11-25
Company comments 80mg and 400mg are being used to supplement for any 200mg usage
Health Canada comments
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-11-25 English Compare
v8 2021-11-02 French Compare
v7 2021-11-02 English Compare
v6 2021-10-27 French Compare
v5 2021-10-27 English Compare
v4 2021-09-08 French Compare
v3 2021-09-08 English Compare
v2 2021-08-23 French Compare
v1 2021-08-23 English Compare